NANOG and hepatocellular carcinoma: As a result, the upregulation of miR-589-5p was found to promote HCC stemness by upregulating the expression of CSC-associated surface marker CD133 and CSC-associated markers NANOG, BMI-1, OCT-4, and SOX2, and promoting tumorigenesis in vivo [111].